Equities

Diaceutics PLC

DXRX:LSE

Diaceutics PLC

Health CareHealth Care Providers
  • Price (GBX)166.00
  • Today's Change-2.00 / -1.19%
  • Shares traded381.24k
  • 1 Year change24.81%
  • Beta1.9906
Data delayed at least 20 minutes, as of Feb 06 2026 16:47 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Diaceutics PLC grew revenues 35.69% from 23.70m to 32.16m while net income improved from a loss of 1.75m to a smaller loss of 1.70m.
Gross margin86.12%
Net profit margin-4.42%
Operating margin-5.96%
Return on assets-3.38%
Return on equity-4.00%
Return on investment-3.89%
More ▼

Cash flow in GBPView more

In 2024, cash reserves at Diaceutics PLC fell by 3.92m. However, the company earned 651.00k from its operations for a Cash Flow Margin of 2.02%. In addition the company used 4.03m on investing activities and also paid 64.00k in financing cash flows.
Cash flow per share0.0418
Price/Cash flow per share39.90
Book value per share0.4404
Tangible book value per share0.2587
More ▼

Balance sheet in GBPView more

Diaceutics PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio3.96
Quick ratio--
Total debt/total equity0.0305
Total debt/total capital0.0296
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 2.75%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		46.69
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.